Strata Critical Medical (SRTA) Q2 FY26 earnings call

Strata Critical Medical delivered a strong second quarter, marked by robust organic growth and strategic acquisitions in its clinical services segment, which now represents a larger portion of the business with higher margins. Despite short-term headwinds in logistics, including a customer volume reduction and margin compression, the company is proactively implementing initiatives to restore profitability and is well ahead of its capital deployment plan, positioning for continued cash generation and long-term success.